Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide in COVID-19 (DEFEAT-COVID)
NCT05007678Phase 3Completed
- Sponsor
- Ashford and St Peter's Hospitals NHS Foundation Trust
- Start
- Sep 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of leflunomide in coronavirus disease 2019 (COVID-19), sponsored by Ashford and St Peter's Hospitals NHS Foundation Trust. Started Sep 2020; status: completed.
02
Drugs
leflunomide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05007678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05007678.